KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway

Zhang, W., Ruan, X., Li, Y., Zhi, J., Hu, L., Hou, X., Shi, X., Wang, X., Wang, J., Ma, W., Gu, P., Zheng, X., & Gao, M. (2022). KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway. Theranostics, 12(4), 1500–1517. https://doi.org/10.7150/thno.66142
Authors:
Wei Zhang
Xianhui Ruan
Yaoshuang Li
Jingtai Zhi
Linfei Hu
Xiukun Hou
Xianle Shi
Xin Wang
Jinpeng Wang
Weike Ma
Pengfei Gu
Xiangqian Zheng
Ming Gao
Affiliated Authors:
Xianle Shi
Author Keywords:
kdmia
thyroid cancer
wnt/beta-catenin pathway
stemness
target therapy
wnt/β-catenin pathway
Publication Type:
Article
Unique ID:
10.7150/thno.66142
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: